CTSD and hyperinsulinemic hypoglycemia, familial, 4: Cts D-deficiency achieved either by treatment with pepstatin A (a specific inhibitor of cathepsin D) or generation of Ctsd–/– cells, results in increase in the number of viable bacteria (Fu et al., 2020).